Amanta Healthcare Intrinsic Value
Amanta Healthcare intrinsic value. Amanta Healthcare (AMANTA) median intrinsic value is ₹92.40 from 9 valuation models (range ₹64–₹154), vs current price ₹157.14 — -41.2% downside (Trading Above Calculated Value), margin of safety -70.1%. Compare with AMANTA DCF valuation to assess whether the stock is under or overvalued.
AMANTA Valuation Methods Summary — DCF, Graham Number & P/E
Amanta Healthcare intrinsic value across 9 models vs current price ₹157.14 — upside/downside and value range per method. For current market price and key ratios, visit Amanta Healthcare share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹92.40 | ₹73.92 - ₹110.88 | -41.2% | EPS: ₹4.20, Sector P/E: 22x |
| Book Value Method | asset | ₹112.82 | ₹101.54 - ₹124.10 | -28.2% | Book Value/Share: ₹56.41, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹150.77 | ₹135.69 - ₹165.85 | -4.1% | Revenue/Share: ₹75.38, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹153.85 | ₹138.47 - ₹169.24 | -2.1% | EBITDA: ₹60.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹116.64 | ₹93.31 - ₹139.97 | -25.8% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹67.20 | ₹60.48 - ₹73.92 | -57.2% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹63.89 | ₹57.50 - ₹70.28 | -59.3% | Revenue Growth: 2.8%, Adj P/E: 15.2x |
| ROE Based Valuation | profitability | ₹78.57 | ₹70.71 - ₹86.43 | -50.0% | ROE: 6.8%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹73.01 | ₹65.71 - ₹80.31 | -53.5% | EPS: ₹4.20, BVPS: ₹56.41 |
AMANTA Intrinsic Value vs Market Price — All Valuation Models
Amanta Healthcare fair value range ₹64–₹154 vs current market price ₹157.14 across 9 valuation models. Read AMANTA dividend history for the complete payout history and dividend yield track record.
AMANTA Intrinsic Value Analysis — Undervalued or Overvalued?
Amanta Healthcare median intrinsic value ₹92.40, current price ₹157.14 — Trading Above Calculated Value by 41.2%, margin of safety -70.1%.
What is the intrinsic value of AMANTA?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Amanta Healthcare (AMANTA) is ₹92.40 (median value). With the current market price of ₹157.14, this represents a -41.2% variance from our estimated fair value.
The valuation range spans from ₹63.89 to ₹153.85, indicating ₹63.89 - ₹153.85.
Is AMANTA undervalued or overvalued?
Based on our multi-method analysis, Amanta Healthcare (AMANTA) appears to be trading above calculated value by approximately 41.2%.
AMANTA Financial Health — Key Ratios vs Industry Benchmarks
Amanta Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.21 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 6.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 20.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.53x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
AMANTA Cash Flow Quality — Operating & Free Cash Flow
Amanta Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹49 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2025 | ₹47 Cr | ₹35 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹58 Cr | ₹53 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹43 Cr | ₹40 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹62 Cr | ₹59 Cr | Positive Free Cash Flow | 8/10 |